KaloCyte, Inc.
PrivateLast Round
Seed
Feb 24, 2025
Total Funding Raised
$24.13M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
KaloCyte, Inc. is a biotechnology company developing ErythroMer™, a dried, bio-inspired artificial red blood cell substitute for use when stored red blood cells are unavailable.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KaloCyte, Inc. Comparables
Compare KaloCyte, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VirTech Bio | 85% | |
| NanoBlood LLC | 85% | |
| Fluoro2 Therapeutics | 82% |
KaloCyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 24, 2025 | ||||
| Grant | Feb 1, 2025 | ||||
| Grant | Jan 28, 2025 | ||||
| Grant | Apr 15, 2024 | ||||
| Grant | Aug 22, 2023 | ||||
Debt | Jul 17, 2023 |
Key People
Founding team and executive leadership
KaloCyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Debt |
| BioGenerator Ventures | Angel |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Old Line Capital Partners | Convertible Debt |
| Ferocity Capital | Seed |
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 114% MoM.
- Feb 24, 2025
$2.6M round led by Ferocity Capital
KaloCyte, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KaloCyte, Inc.'s valuation, stock price, and market status.
Is KaloCyte, Inc. a public or private company?
KaloCyte, Inc. is a private company.
What is the current stock price of KaloCyte, Inc.?
KaloCyte, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is KaloCyte, Inc. worth (valuation)?
Valuation information for KaloCyte, Inc. is not publicly available.
Can I buy KaloCyte, Inc. stock?
KaloCyte, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KaloCyte, Inc.'s last funding round?
KaloCyte, Inc.'s most recent funding round was Grant on April 15, 2024.
Who are the main investors in KaloCyte, Inc.?
Key investors in KaloCyte, Inc. include NIH RADx, TEDCO, Old Line Capital Partners, University System of Maryland Momentum Fund, Defense Advanced Research Projects Agency.
Will KaloCyte, Inc. IPO soon?
No public IPO plans have been announced for KaloCyte, Inc..
How can I track KaloCyte, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KaloCyte, Inc.'s secondary market activity and sign up for updates.